Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: DrugBank:EXPT01586 (
G418
)
2,237
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To construct the specific siRNA expression vectors and investigate their effect on
leptin
and collagen I in HSC, which provide a new approach to the prevent and treat hepatic fibrosis. The five siRNAs against
leptin
gene were transcript synthesized intracellularly by expression templates of plasmid vector psiRNA-hH1neo. The recombinant
leptin
siRNA plasmid vectors could express in eukaryocyte, and then to evaluate them by using enzyme cutting and sequencing. The recombinant plasmids were transfected into HSCs using Lipofectamine methods respectively. The cells were selected after growing in DMEM containing 300 microg/mL
G418
for about 4 weeks. Gene expression of
leptin
and collagen I were showed by Western blot analysis and reverse transcription polymerase chain reaction (RT-PCR). Identification by enzyme cutting and sequencing showed that the
leptin
siRNA expression vectors were constructed successfully, and
leptin
siRNA could inhibit the
leptin
and collagen I gene expression effectively. It was concluded that RNA interference-mediated silencing of
leptin
gene diminished
leptin
and collagen I gene expression in HSCs. Furthermore, attenuated the extracellular matrix over-deposition at the same time. Leptin gene is ideal targets of gene therapy for liver fibrosis.
...
PMID:RNA interference targeting leptin gene effect on hepatic stellate cells. 1669 17